✉news TechnologyTechnology first seen 5 d ago, last 5 d ago, peak #27
Okomera Signs Commercial Agreement With Servier for Cancer Research Technology
Original: Okomera Announces a Commercial Agreement With Servier to Use Its Tumor Miniaturization Technology for Cancer Research
French biotech Okomera has announced a commercial agreement with pharmaceutical company Servier to apply its tumor miniaturization technology to cancer research. The deal will let Servier use Okomera's platform, which miniaturizes tumor samples, in its oncology research work. Financial terms were not disclosed in the announcement.
Why now: The announcement is new corporate news about a partnership between a biotech and a major pharmaceutical company in oncology research.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/3117173